1015 Capital Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3K Buy
337
+4
+1% +$195 0.02% 191
2026
Q1
$14.3K Sell
333
-10
-3% -$430 0.01% 209
2025
Q4
$15K Buy
+343
New +$14.2K 0.01% 205

Other funds holding EXEL

1015 Capital Partners's EXEL Position: Q2 2026 in Review

1015 Capital Partners increased its Exelixis (EXEL) stake by 1.2% in Q2 2026, buying an estimated $195 and bringing the position to 337 shares worth $18.3K. The position accounts for 0.02% of the portfolio, ranked #191.

1015 Capital Partners first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. 752 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • 1015 Capital Partners held 337 shares of Exelixis worth $18.3K as of Q2 2026.
  • 1015 Capital Partners bought 4 Exelixis shares in Q2 2026, an estimated $195.
  • Exelixis made up 0.02% of 1015 Capital Partners's portfolio in Q2 2026, its #191 holding.
  • 1015 Capital Partners first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • 752 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.